Promising Epilepsy Treatment Suppresses Neuroinflammation | Neuroscience
LabRoots,
A team of City University of Hong Kong (CityU) neuroscientists recently identified and developed a new drug candidate for…
Promising Epilepsy Treatment Suppresses Neuroinflammation | Neuroscience
LabRoots,
A team of City University of Hong Kong (CityU) neuroscientists recently identified and developed a new drug candidate for…
Promising Epilepsy Treatment Suppresses Neuroinflammation | Neuroscience
LabRoots,
A team of City University of Hong Kong (CityU) neuroscientists recently identified and developed a new drug candidate for…
Neuroscientists discover a new drug candidate for treating epilepsy
Pharmatutor,
Temporal lobe epilepsy (TLE) is one of the most common types of epilepsy worldwide.
Neuroscientists discover a new drug candidate for treating epilepsy - News Azi
News Azi,
Temporal lobe epilepsy (TLE) is one of the most common types of epilepsy worldwide.
Neuroscientists discover a new drug candidate for treating epilepsy - ScienceDaily - swifttelecast
Swift Telecast,
Temporal lobe epilepsy (TLE) is one of the most common types of epilepsy worldwide.
Neuroscientists discover a new drug candidate for treating epilepsy - ScienceDaily - Verve times
Verve times,
Temporal lobe epilepsy (TLE) is one of the most common types of epilepsy worldwide.
Drug Candidate for Epilepsy Treatment Identified
Medindia,
Neuroinflammation is caused by the abnormal functioning of reactive glial cells, such as astrocytes and microglia, causing an…
Tackling epilepsy with a potential new drug
AZO Life Sciences,
One of the epilepsy types that are most prevalent worldwide is temporal lobe epilepsy (TLE).
Neuer Medikamentenkandidat zur Behandlung von Epilepsie entwickelt ~ Nach Welt
Nachrichten Welt,
Temporallappenepilepsie (TLE) ist eine der weltweit häufigsten Epilepsiearten. Obwohl symptomatische Medikamente verfügbar sind…
CityU neuroscientists discover new drug candidate for treatment of epilepsy - journalbreak
journalbreak.Com,
Temporal lobe epilepsy (TEL) is one of the most common types of epilepsy worldwide.
CityU neuroscientists discover new drug candidate for treatment of epilepsy
Mirage News,
City University of Hong Kong Temporal lobe epilepsy (TLE) is one of the most common types of epilepsy worldwide.
News New Drug Candidate Developed for Epilepsy Treatment Researchers have identified and developed a new drug candidate that has the potential for effectively treating temporal lobe epilepsy by suppressing neuroinflammation.
Technology Networks,
Temporal lobe epilepsy (TLE) is one of the most common types of epilepsy worldwide.
Neuroscientists discover a new drug candidate for treating epilepsy
Today UK News,
D4 treatment decreases the proliferation and activation of astrocytes in two different brain regions.
Neuroscientists discover a new drug candidate for treating epilepsy
MedicalXpress,
Temporal lobe epilepsy (TLE) is one of the most common types of epilepsy worldwide.
CityU neuroscientists discover a new drug candidate for treating epilepsy
ScienMag,
Temporal lobe epilepsy (TLE) is one of the most common types of epilepsy worldwide.
CityU neuroscientists discover a new drug candidate for treating epilepsy
EurekAlert!,
Temporal lobe epilepsy (TLE) is one of the most common types of epilepsy worldwide.
CityU neuroscientists discover a new drug candidate for treating epilepsy
Bioengineer.org,
Temporal lobe epilepsy (TLE) is one of the most common types of epilepsy worldwide.